EVFCX
Price
$10.11
Change
-$0.01 (-0.10%)
Updated
Aug 15 closing price
Net Assets
48.76M
FIKVX
Price
$14.11
Change
-$0.01 (-0.07%)
Updated
Aug 15 closing price
Net Assets
5.49B
Interact to see
Advertisement

EVFCX vs FIKVX

Header iconEVFCX vs FIKVX Comparison
Open Charts EVFCX vs FIKVXBanner chart's image
E-Valuator Cnsv (15%-30%) RMS R4
Price$10.11
Change-$0.01 (-0.10%)
VolumeN/A
Net Assets48.76M
Fidelity Advisor Asset Manager 20% Z
Price$14.11
Change-$0.01 (-0.07%)
VolumeN/A
Net Assets5.49B
EVFCX vs FIKVX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
EVFCX vs. FIKVX commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVFCX is a StrongBuy and FIKVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FIKVX has more cash in the bank: 5.49B vs. EVFCX (48.8M). FIKVX (3.25) and EVFCX (3.23) have matching dividends . EVFCX was incepted earlier than FIKVX: EVFCX (9 years) vs FIKVX (7 years). EVFCX (1.47) is less costly to investors than FIKVX (0.46). EVFCX is a more actively managed with annual turnover of: 52.00 vs. FIKVX (24.00). FIKVX has a lower initial minimum investment than EVFCX: FIKVX (0) vs EVFCX (10000). EVFCX annual gain was more profitable for investors over the last year : 7.46 vs. FIKVX (6.44). FIKVX return over 5 years is better than : 14.33 vs. EVFCX (6.30).
EVFCXFIKVXEVFCX / FIKVX
Total Expense Ratio1.400.46304%
Annual Report Gross Expense Ratio1.470.46320%
Fund Existence9 years7 years-
Gain YTD7.1176.068117%
Front LoadN/AN/A-
Min. Initial Investment100000-
Min. Initial Investment IRAN/AN/A-
Net Assets48.8M5.49B1%
Annual Yield % from dividends3.233.25100%
Returns for 1 year7.466.44116%
Returns for 3 years16.5913.62122%
Returns for 5 years6.3014.3344%
Returns for 10 years19.48N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLC0.05N/A
+1.64%
Oncotelic Therapeutics, Inc.
BPIRF8.00N/A
N/A
Piraeus Financial Holdings S.A.
APMSF30.50N/A
N/A
Aperam S.A.
WELUF12.19N/A
N/A
Integrated Wellness Acquisition Corp.
MLGF20.16-0.02
-0.10%
Malaga Financial Corp.